At a glance
- Originator Nonindustrial source
- Class Benzamides; Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 30 Mar 2007 Discontinued - Preclinical for Anxiety disorders in USA (unspecified route)
- 07 Dec 2000 Preclinical development for Anxiety disorders in USA (Unknown route)